ARTICLE
Received 14 Sep 2016 | Accepted 7 Feb 2017 | Published 16 Mar 2017
Carbohydrates are diverse bio-macromolecules with highly complex structures that are involved in numerous biological processes. Well-dened carbohydrates obtained by chemical synthesis are essential to the understanding of their functions. However, synthesis of carbohydrates is greatly hampered by its insufcient efciency. So far, assembly of long carbohydrate chains remains one of the most challenging tasks for synthetic chemists. Here we describe a highly efcient assembly of a 92-mer polysaccharide by the preactivation-based one-pot glycosylation protocol. Several linear and branched oligosaccharide/ polysaccharide fragments ranging from 5-mer to 31-mer in length have been rapidly constructed in one-pot manner, which enables the rst total synthesis of a biologically important mycobacterial arabinogalactan through a highly convergent [31 31 30] coupling
reaction. Our results show that the preactivation-based one-pot glycosylation protocol may provide access to the construction of long and complicated carbohydrate chains.
DOI: 10.1038/ncomms14851 OPEN
Total synthesis of mycobacterial arabinogalactan containing 92 monosaccharide units
Yong Wu1, De-Cai Xiong1, Si-Cong Chen1, Yong-Shi Wang1 & Xin-Shan Ye1
1 State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Xue Yuan Road No. 38, Beijing 100191, China. Correspondence and requests for materials should be addressed to X.-S.Y. (email: mailto:[email protected]
Web End [email protected] ).
NATURE COMMUNICATIONS | 8:14851 | DOI: 10.1038/ncomms14851 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 1
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14851
Carbohydrates are involved in many key biological processes, such as cell signaling, cell proliferation and differentiation and viral and bacterial infections, as well as
immunoresponse13. Naturally occurring carbohydrates and glycoconjugates usually exist in microheterogeneous forms, making the isolation of pure carbohydrates and glycoconjugates from natural sources difcult or even impossible in most cases. Therefore, chemical synthesis becomes the main approach to obtain well-dened carbohydrates47. However, unlike peptides and oligonucleotides, which can be routinely prepared by automated solid-phase synthesizers, the oligosaccharide synthesis is much more difcult. The major challenge for oligosaccharide preparation is the regio- and stereochemistry8,9 issues in each glycosidic bond formation, making oligosaccharide synthesis a tedious and time-consuming process. Therefore, oligosaccharide synthesis becomes a daunting task, especially when polysaccharides are chosen as the target molecules. Indeed, only a few examples of the synthesis of oligosaccharide sequences containing 420 units have been reported over the past few decades1018. These syntheses are challenging because multiple steps of protective group manipulation and intermediate purication are required in most cases.
Arabinogalactan is an essential structural constituent of mycobacterial cell wall, which plays critical roles in the infectivity and pathogenicity of Mycobacterium tuberculosis19. Based on experiments and analyses2022, the primary structure of arabinogalactan has been established as a linear galactan composed of about 30 alternating b-(1-5)-linked and b-(1-6)-linked D-galactofuranose (Galf) residues, to which up to two22 highly branched arabinan chains (each containing 31 D-arabinofuranose (Araf) residues) are attached. The arabinogalactan motifs are useful probes for investigating the biosynthesis of mycobacterial cell wall, especially for characterization of the enzymes that process this polysaccharide, and those enzymes are attractive targets for the development of new antituberculosis drugs23. To this end, some solution phase14,15,2427 and automated solid-phase28 strategies have been developed for the assembly of motifs up to 22 residues, among which the Lowary group14 and Ito group15 have elegantly synthesized the docosasaccharide arabinan motif via the convergent [5 5 12]
and [7 7 8] coupling strategies, respectively. While almost all
these syntheses relied upon the stepwise synthesis of oligosaccharide fragments, the object of this study is to achieve the total synthesis of the whole complex polysaccharide rather than the truncated fragments in an efcient way.
In the preactivation-based one-pot glycosylation strategy, several glycosyl donors are allowed to react sequentially in the same vessel regardless of the anomeric reactivities, generating a single oligosaccharide as the main product, which can signicantly simplify the synthetic process and increase the overall efciency29. Herein, by utilizing the preactivation-based one-pot glycosylation protocol, we report the rst total synthesis of a biologically important mycobacterial arabinogalactan composed of 92 monosaccharide units. Our synthetic strategy involves: (1) several scalable one-pot coupling reactions to generate the linear and branched oligosaccharide fragments, (2) the stereoselective b-arabinofuranosylation by preactivation protocol, (3) the further one-pot coupling reactions of oligosaccharide fragments for the rapid assembly of polysaccharides up to 31-mer, and (4) the convergent [31 31 30] coupling reaction for the nal
construction of the target polysaccharide.
ResultsRetrosynthetic analysis. The target polysaccharide arabinogalactan 1 was disconnected into two sizeable fragments, that is, the
linear Galf30 acceptor 2 and the branched Araf31 donor 3 (Fig. 1). It was conceived that Galf30 acceptor 2 would be rapidly assembled via a ve-component one-pot coupling of several oligosaccharide fragments 47. As for the synthesis of Araf31 donor 3, oligosaccharide fragments 1012 were designed to carry out a four-component one-pot glycosylation reaction. For the preparation of heptasaccharide 10, thioglycoside donors 13ac and thioglycoside acceptor 14 were planned for the construction of the challenging b-arabinofuranosyl linkages.
Finally, it was expected that all the oligosaccharide fragments (8, 9, 1517) would be accessible by the preactivation-based one-pot oligosaccharide synthesis starting from various monosaccharide building blocks. Overall, it was anticipated that the major challenge of our plan towards the total synthesis of arabinogalactan 1 would rely on the efciency of one-pot glycosylation reactions, especially when large oligosaccharide fragments were attempted as the components in one-pot coupling reactions.
Synthesis of Galf30 acceptor 2. To test our one-pot strategy for oligosaccharide synthesis, three monosaccharide building blocks 1820 were designed and synthesized (Supplementary Fig. 1). Using these building blocks, the assembly of hexasaccharide 8 in a six-component one-pot manner (18 19 20 19 20 19) by preactivation protocol was
tried, which should be rather challenging as up to ve glycosidic linkages must be correctly constructed. To our delight, when promoted by stoichiometric p-toluenesulfenyl chloride/silver triate (p-TolSCl/AgOTf)29, all glycosylation steps underwent smoothly and none of the side products interfered with the reaction. After optimization of the reaction conditions, hexasaccharide 8 was obtained in 63% overall yield and on a perfect scale (1.07 g) within several hours (Fig. 2a). The desilylation of 8 provided 5 (85% yield), which was re-protected with benzoyl group to give 4 in 96% yield. Subsequently, the coupling reaction of 8 with 1-octanol afforded 21 (91% yield), which was followed by desilylation to provide 6 in 87% yield.
With hexasaccharides 46 in hand, the further iterative one-pot glycosylation was performed. The ve-component one-pot coupling of these oligosaccharides (4 5 5 5 6)
was realized successfully, producing the 30-mer polysaccharide 22 in 68% overall yield (Fig. 2b). It was noteworthy that some deletion sequences were difcult to be removed by column chromatography on silica gel. Gratifyingly, given the difference in molecular weight between the deletion sequences and desired product, size exclusion chromatography was then used to obtain the pure 30-mer polysaccharide 22 (Supplementary Fig. 2). The identity of 22 was conrmed by its nuclear magnetic resonance (NMR) and matrix-assisted laser desorption/ ionizationtime of ight (MALDI-TOF) mass spectra (see Supplementary Information for details). Finally, the global deprotection of 22 via successive debenzoylation and debenzylation provided the 30-mer galactan 23 ([M Na] m/z calcd.
for 5017.4, found: 5018.1).
Having established a highly efcient one-pot approach to the synthesis of polysaccharide up to 30-mer, we turned to accomplish the construction of Galf30 acceptor 2. As shown in
Fig. 1, an additional hexasaccharide 9 equipped with two levulinoyl groups was needed. Initially, monosaccharide 24a (Supplementary Fig. 3) was designed as a building block for a six-component one-pot assembly of 9. However, the efforts failed due to the migration of levulinoyl group from the O-5 to O-6 position. As an alternative route, disaccharide 24b was synthesized (Supplementary Fig. 3). Therefore, a four-component one-pot coupling reaction (18 24b 24b 19) nally gave the
2 NATURE COMMUNICATIONS | 8:14851 | DOI: 10.1038/ncomms14851 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14851 ARTICLE
OH
HO
O
HO
HO O
O
OH
O OH
OH
O OH O
OH
O
O
OH
O
HO O
OH
O
O
O
OH
O
OH
OH
OOH
O
HO HO
OH
OH
HO
O
Arabinan
O
OH
O
OH
OH
O OH
O
HO
O
HO O
O
HO
O
OC H
O
13
O
OH
HO
O
O
HOO
HO
OH
O
OH O
OH
O OH
HOO HO
OH
O
HO
O
HO O
OH
O
HO O
OH
O
O
O
OH
O
OH
O OH O
OH
O
OH
O OH
HOO
HO
O OH
OH
O
HOO
O
OH
HO HO
O
O
3
O
HO HO
OH
O
HO O
OH
O
O
OH
HOO
HO
O OH
O OH
OH
OOH
OH
O OH
OH
O OH
O
OH
OH
O
O
OH
HO
O
Arabinan
HO
O
O
HOO
O
13
O
HO
Galactan
HO O
O
OH
O
O
OH
OH
O OH
HOO
HO
O OH
O
O
HOO HO
O
OH
O
OH
OH
O
HO O
OH
O
O
OH
O OH
HOO HO
HO HO
O
O
HOO
HO
OH
9
HO OH
Arabinogalactan 1
OBz
BnO
O
BzO
[31+31+30]
BnO O
O
O OBz O
OBn
O OBz
OBn
OBz
O
O
OC H
O
O
OBn
O OBz
OBn
OOBz
O
BnOO BnO
BnOO
BnO
OBn
O
BnO O
OBz
O
O
OBz
BzO BnO
OBn
O OBz
BnOO
BnO
O OBz
OBn
O OBz
O
OBz
O
O
OBz
BnO
O
O
STol
BnOO HO
O
OBz
O
OBn
3
BzO
13
BnO O
O
BnOO BnO
O
BnOO
BnO
O OBz
OBz
OBn
O
O
OBz
O OBn
O OBz
O
O OBz
2
OBn
O
BnO O
OBz
O
O
OBz
O
O
OBn
BnOO BnO
BnOO
BnO
OBz
BzO BnO
O
BzO OBz
9
Araf31 donor 3
Galf30 acceptor 2
7: R1 = H, R2 = Lev, R3 = STol9: R1 = TBS, R2 = Lev, R3 = STol
one pot[7 + 7 + 5 + 6 + 6]
one pot[6 + 6 + 6 + 6 +6]
OBz
BnO
O
R
BzO
RO
O
BnOO R O
BnOO
BnO
BnO O
OOBz
OBn
OOBz
OBz
O
OBz
OBn
O OBz
OBn
O OBz O
OBz
OBn
O OBz O
OBn
O OBz
O STol
OBz
RO
OBz
O
BnOO
BnO
O
OBz
O
O
O
O
OBn
O OBz
O
O
OBz
O
STol
O
STol
BnO
BnOO
R O
O
OBz
OBn
O
BnO O
OBz
O
O
OBn
O
OBn
OBn
OBn
2
4
RO
BzO BnO
10 11: R = H
16: R = TBS
12: R = H
17: R = TBS
Arabinofuranosylation
4: R1 = Bz, R2 = Bn, R3 = STol
5: R1 = H, R2 = Bn, R3 = STol
6: R1 = H, R2 = Bn, R3 = OC8H17
8: R1 = TBS, R2 = Bn, R3 = STol
R O
BnO OR
OBn
O
BnO OR
O
O
OR
STol
O OBz O
O
13a: R1 = R2 = R3 = Bn13b: R1, R2 = -TIPDS-, R3 = Bn 13c: R1, R2 = -TIPDS-, R3 = TIPS
OBn
O OBz
O STol
14: R = H
15: R = Lev
OBn
OBz
OR
O
O
OBn
Figure 1 | The structure of mycobacterial arabinogalactan 1 and its retrosynthetic analysis. Bn, benzyl; Bz, benzoyl; Lev, levulinoyl; TBS, tert-butyl-dimethylsilyl; TIPDS, tetraisopropyldisiloxanylidene; TIPS, triisopropylsilyl; Tol, p-tolyl.
NATURE COMMUNICATIONS | 8:14851 | DOI: 10.1038/ncomms14851 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 3
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14851
a
19
c
BnO
BnOO
HO
STol
OBz
BnOO LevO
STol
24b
OBz
19
HO
BnOO
BnO
O
OBz
24b
19
HO
BnOO
BnO
STol
OBz
19
R
(12)
O
BnO
BnOO
TBSO
STol
OBz
BnOO BnO
BnOO
BnO
18
OBz
18
STol
OBz
O
BnOO
BnO
O
OBz
BnOO LevO
BnOO
BnO
OBz
OBz
BnO
BnOO
R O
O
OBz
2
O
OBz
BnO
BnOO
RO
O
OBz
BnOO
BnO
2
85% (4)
96% (5)
87% (4)
8: R1 = TBS, R2 = STol 5: R1 = H, R2 = STol4: R1 = Bz, R2 = STol 21: R1 = TBS, R2 = OC8H17
6: R1 = H, R2 = OC8H17
(6) 91%
90% (4)
85% (15)
9: R = TBS 7: R = H
5
b
5
d
5
6
5
(7)
OC H
4
O
(7)
BnOO BnO
BnOO
BnO
6
OBz
R OO
R O
OC H
BnOO
BnO
O OBz
R OO R O
O
BnOO RO
O
OBz
OR
3
O
OR
BnOO
BnO
O OBz
OR
BnOO BnO
O
R OO
R O
O
OR
R OO
R O
OBz
R O
14
22: R1 = Bz, R2 = Bn 23: R1 = R2 = H
O OBz
2
O
BnOO BnO
BnOO
BnO
OBz
(10), (11)
78%, 2 steps
25: R = Lev 2: R = H
BzO OBz
9
Figure 2 | Synthesis of Galf30 acceptor 2. (a) Synthesis of oligosaccharides 46; (b) Synthesis of 30-mer galactan 23; (c) Synthesis of hexasaccharide 7; (d) Synthesis of Galf30 acceptor 2. Reagents and conditions: (1) TTBP, 4 MS, CH2Cl2, p-TolSCl, AgOTf, then 19, 78 C to room temperature;
(2) p-TolSCl, AgOTf, then 20, 78 C to room temperature; (3) p-TolSCl, AgOTf, then 19, 78 C to room temperature; (4) HF-pyridine, THF/H2O (10:1),
35 C; (5) Bz2O, DMAP, pyridine, CH2Cl2, reux; (6) p-TolSCl, AgOTf, TTBP, 1-octanol, 4 MS, CH2Cl2, 78 C; (7) TTBP, 4 MS, CH2Cl2, p-TolSCl,
AgOTf, then 5, 78 C to room temperature; (8) p-TolSCl, AgOTf, then 5, 78 C to room temperature; (9) p-TolSCl, AgOTf, then 6, 78 C to
room temperature; (10) NaOCH3, CH3OH/CH2Cl2 (2:1); (11) Pd/C, H2, EtOAc/THF/1-PrOH/H2O (2:1:1:1); (12) TTBP, 4 MS, CH2Cl2, p-TolSCl, AgOTf, then 24b, 78 C to room temperature; (13) p-TolSCl, AgOTf, then 24b, 78 C to room temperature; (14) p-TolSCl, AgOTf, then 7, 78 C to room
temperature; (15) H2NNH2-AcOH, THF/CH3OH (10:1). DMAP, 4,4-dimethylaminopyridine; MS, molecular sieves; TTBP, 2,4,6-tri-tert-butylpyrimidine.
desired hexasaccharide 9 in 79% yield (Fig. 2c), which was subjected to desilylation to afford 7 (90% yield). Subsequently, polysaccharide 25 was assembled in a ve-component one-pot manner as described in the construction of 22 by coupling the oligosaccharide fragments (4 5 5 7 6) in
64% overall yield (Fig. 2d). Exposure of 25 to hydrazine acetate successfully fullled the preparation of the desired Galf30 acceptor 2 (85% yield).
Synthesis of Araf31 donor 3. The assembly of the branched Araf31 donor 3 required three oligosaccharide intermediates, that is, b-Araf-containing heptasaccharide 10, branched pentasaccharide 11 and linear hexasaccharide 12. For this purpose, a set of arabinofuranosyl building blocks (13ac, 2629) were designed and synthesized (Supplementary Fig. 4). A six-component iterative one-pot glycosylation of monosaccharides 26 and 27 (26 27 27 27 27 27) afforded
hexasaccharide 17 in excellent yield (73%) and on gram scale(1.20 g) (Fig. 3a). The desilylation of 17 resulted in the desired hexasaccharide 12 (92% yield). Likewise, the one-pot coupling reaction of building blocks 26, 28 (ref. 30) and 27 provided a branched pentasaccharide 16 very smoothly (78% yield), which was further converted into diol 11 by desilylation in 95% yield (Fig. 3b). For the preparation of heptasaccharide 10, another diol
14 was required. Initially, the glycosyl donor 29a (ref. 31) with chloroacetyl group at the O-2 position was chosen for the one-pot construction of pentasaccharide 15a (Supplementary Table 1), but the overall yield was moderate (43%). Fortunately, when the donor 29 equipped with a levulinoyl group was employed for the one-pot glycosylation reaction, pentasaccharide 15 was rapidly assembled in 76% overall yield (Fig. 3b). Ultimately, deacylation of 15 gave diol 14 (94% yield).
Our attention was then turned to the synthesis of heptasaccharide 10, which involved the stereocontrolled installation of two challenging b-arabinofuranosyl linkages. Among a number of innovative glycosyl donors developed by several groups25,3137, perbenzyl-protected thioglycoside 13a (ref. 25) and 3,5-O-tetraiso propyldisiloxanylidene-protected thioglycosides 13b,c (ref. 31) were synthesized for the current purpose (Supplementary Table 2). Although these donors proved useful for direct b-arabinofuranosylation, whether they could be subjected to thioglycoside acceptor 14 under the donor-preactivation conditions38 remained to be explored. After some optimization, the best result arised when 4.0 equiv. of 13b was preactivated by p-TolSCl/AgOTf and subsequently glycosylated with 1.0 equiv. of diol 14, delivering heptasaccharide 30b with good stereoselectivity (b,b-isomer/other isomers 9/1). Removal of
the silyl groups in 30b afforded 31 (74% over two steps, Fig. 3c), in which the newly formed b-arabinofuranosyl linkages were
4 NATURE COMMUNICATIONS | 8:14851 | DOI: 10.1038/ncomms14851 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14851 ARTICLE
a
c
27 27
OR
BnO
O
R O
BnO O
O
HO
OBz
STol
O
27
27
(7)
OBn
O OBz
O
Si O STol
Si
14
OBn
OBn
O OBz O
OBz
O
O
OBn
OBn
O
BnO O
OR
O
O
STol
O
O
O
OBn
TBSO
OBz
STol
O
26
R O
OBz
O
OBz
OBn
O OBz
O
O
13b
R O BnO
OBn
OBn
O
OBn
R
4
17: R1 = TBS, R2 = STol
32: R1 = H, R2 = OC8H17
12: R1 = H, R2 = STol
30b: R1, R2 = -TIPDS-
92% (3)
(4), (3)
74% (8)
86%2 steps (9) 97%
2 steps
31: R1= R2 = H 10: R1= R2 = Bz
b
d
11
HO
OOBz
STol
OR
R O
O
HO
10
12
12 or 32
HO
OOBz
STol
OBn
R O
28 27
R O O
O
OR
O OR
OR
O OR O
OR
TBSO
BnO
O
O
OOBz
STol
or
OOLev
STol
(5)
OR
O
R O O
OR
O
O
27
O
OR
OBn
OBn
O
26
OR
OR
OOR
29
R O R O
O
OR
O OR
O
OR
R O
OR
O OR
O
O
OOR
OBn
OOR
OR
R O
O
O
R
O
OR
OBn
O OBz O
OBn
O OBz
O STol
OBz
O
13
O
R O
R O O
O
O
OBn
OR
O
O
OR
O OR
O OR
O
O
OR
R O
16: R1 = TBS, R2 = Bz 11: R1 = H, R2 = Bz
O
OR
95% (3)
94% (6)
R O R O
O
OR
O
R O O
OR
O
3: R1 = Bz, R2 = Bn, R3 = STol
15: R1 = Bn, R2 = Lev 14: R1 = Bn, R2 = H
33: R1 = Bz, R2 = Bn, R3 = OC8H17 34: R1 = R2 = H, R3 = OC8H17
(13), (14)
83%, 2 steps
Figure 3 | Synthesis of Araf31 donor 3. (a) Synthesis of oligosaccharides 12 and 32; (b) Synthesis of diols 11 and 14; (c) Synthesis of heptasaccharide 10; (d) Synthesis of Araf31 donor 3 and 31-mer arabinan 34. Reagents and conditions: (1) TTBP, 4 MS, CH2Cl2, p-TolSCl, AgOTf, then 27, 78 C to room
temperature; (2) p-TolSCl, AgOTf, then 27, 78 C to room temperature; (3) TBAF, AcOH, THF; (4) p-TolSCl, AgOTf, TTBP, 1-octanol, 4 MS, CH2Cl2, 78 C; (5) TTBP, 4 MS, CH2Cl2, p-TolSCl, AgOTf, then 28, 78 C to room temperature; (6) H2NNH2-AcOH, THF/CH3OH (10:1); (7) p-TolSCl, AgOTf,
then 14, 78 C; (8) TBAF, THF; (9) Bz2O, DMAP, pyridine, CH2Cl2, reux; (10) TTBP, 4 MS, CH2Cl2, p-TolSCl, AgOTf, then 11, 78 C to room
temperature; (11) p-TolSCl, AgOTf, then 12, 78 C to room temperature; (12) p-TolSCl, AgOTf, then 12 or 32, 78 C to room temperature; (13) NaOCH3,
CH3OH/CH2Cl2 (2:1); (14) Pd/C, H2, EtOAc/THF/1-PrOH/H2O (2:1:1:1). TBAF, tetra-n-butylammonium uoride.
conrmed by the 13C NMR spectrum (appearance at 99.6 and99.1 p.p.m.)39. Finally, the re-protection of 31 with benzoyl groups yielded the desired heptasaccharide 10 (97% yield).
With oligosaccharide building blocks 1012 in hand, the assembly of Araf31 donor 3 by preactivation-based one-pot glycosylation protocol was attempted. This one-pot reaction was expected to be more challenging due to the steric hindrance in the double glycosylation of Araf5 acceptor 11 using
Araf7 donor 10. Surprisingly, the reaction proceeded smoothly when 2.3 equiv. of 10 was reacted with 1.0 equiv. of 11, delivering an Araf19 intermediate, which was sequentially coupled with two Araf6 acceptors 12 in a single ask without any intermediate isolation to afford the Araf31 donor 3 in 70% overall yield (Fig. 3d). To further conrm the identity of this 31-mer polysaccharide, an Araf6 acceptor 32 bearing an alkyl group at the reducing end was synthesized (Fig. 3a). Thus a four-component one-pot coupling reaction of oligosaccharides 1012 and 32 gave a similar 31-mer polysaccharide 33 in 65% yield (Fig. 3d), which was fully deprotected via deacylation and hydrogenolysis to afford the arabinan 34 ([M Na]
monoisotopic m/z calcd. for 4246.4, found: 4246.3; [M K]
monoisotopic m/z calcd. for 4262.4, found: 4262.2). Gratifyingly, the 1H and 13C NMR data of 34 were found to be identical
with previous reports14,40 except for the differences in some repeating units.
Assembly of arabinogalactan 1. Our nal task was the glycosylation of Galf30 acceptor 2 with Araf31 donor 3 to nish the assembly of target polysaccharide. To the best of our knowledge, no glycosylation reactions between polysaccharide sequences composed of 420 units were reported to date. For the planned [31 31 30] coupling reaction, it was anticipated that the
biggest challenge would come from the steric hindrance by the bulky size of both the donor and acceptor, especially when a double glycosylation was required. Indeed, when a wide variety of promoter systems such as p-TolSCl/AgOTf29, NIS/AgOTf41, NIS/TfOH42, N-(p-methylphenylthio)-e-caprolactam/Tf2O43, TBPA44, Ph3Bi(OTf)2 (ref. 45), BSP/Tf2O46 and Ph2SO/Tf2O47 were examined (Supplementary Table 3), no double glycosylation product or only some monoglycosylation product was observed before the donor decomposed, prompting us to further screen the reaction conditions. Encouragingly, it was found that benzenesulnyl morpholine/triic anhydride (BSM/ Tf2O)48 developed by our group is the most effective promoter.
And indeed, when promoted by BSM/Tf2O, this double
NATURE COMMUNICATIONS | 8:14851 | DOI: 10.1038/ncomms14851 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 5
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14851
OR1
R2O
O
Araf31 donor 3 + Galf30 acceptor 2
(1)
R1O
R2O O
O
84%
OR2
O OR1
OR2
O OR
1 O
OR1
O
O
OR2
O
R2O O
OR1
O
O
OR2
OC8H17
O
O
R2OO
R2O
O
OR1
OR2
OOR1
R2OOR2O OR
1
R1O R
2O
O
OR2
O OR1
O
OR1
R2OO
R2O
O OR1
O
OR2
O OR1
O
OR1
R2O
O
O
OR2
O
O
R2OO
O
OR1
3
R1O
13
R2O O
OR1
O
OR2
O
O
OR1
O OR2
O OR1
R2OO
R2O
O
R2OO R2O
O
O
OR1
OR2
O
R2O O
OR1
O
O
OR1
O
2
OR2
O OR1
R2OO
R1O R
2O
O
O
R2OO
R2O
(2), (3)
75%, 2 steps
Figure 4 | Assembly of arabinogalactan 1. Reagents and conditions: (1) BSM, Tf2O, 4 MS, CH2Cl2, 40 C; (2) NaOCH3, CH3OH/THF (2:1);
(3) Pd/C, H2, EtOAc/THF/1-PrOH/H2O (2:1:1:1). BSM, benzenesulnyl morpholine.
OR1
35: R1 = Bz, R2 = Bn
1: R1 = R2 = H
R2O
9
1
R1O OR
glycosylation was extremely clean and complete (indicated by thin-layer chromatography analysis), delivering the fully protected arabinogalactan 35 in 84% yield (Fig. 4). Although signals of the anomeric protons in 1H NMR spectrum were obscured due to the extensive overlapping, the anomeric carbons were distinctive in 13C NMR spectrum (all anomeric carbons of a-Araf residues and b-Galf residues were between 105 and 107 p.p.m., and anomeric carbons of b-Araf residues appeared at 101.0 and 100.6 p.p.m.). The identity of 35 was further supported by its MALDI-TOF mass spectrum ([M Na] m/z calcd. for
33885.4, found: 33884.7). Finally, the global deprotection of 35 by the successive deacylation and hydrogenolysis was conducted, affording the target polysaccharide arabinogalactan 1 successfully.
DiscussionWe have developed a concise and highly efcient strategy for the rst total synthesis of 92-mer mycobacterial arabinogalactan 1. This work not only represents the longest well-dened carbohydrate chain synthesis up to date, but also provides useful compounds as probes for further investigations on mycobacterial cell wall-related biological events. Our synthetic strategy highlights a series of efcient preactivation-based one-pot glycosylation reactions to minimize the synthetic steps, the stereoselective b-arabinofuranosylation by preactivation protocol and the convergent [31 31 30] double glycosylation reaction,
thus offering a straightforward access to the target polysaccharide. Our work may open an avenue to the synthesis of complex polysaccharides with biological importance that are either difcult or impossible to access through isolation or semisynthesis.
Methods
General. The complete experimental details and compound characterization data can be found in Supplementary Methods. For the NMR, HPLC and MALDI-TOF mass spectra of the compounds in this article, see Supplementary Figs 5126.
General procedure for preactivation-based one-pot glycosylation reaction.
A mixture of glycosyl donor, TTBP and freshly activated 4 molecular sieves in anhydrous CH2Cl2 under argon atmosphere was stirred for 20 min at room
temperature and cooled to 78 C. After 5 min, stoichiometric amount of
p-TolSCl was added to the mixture, followed by the addition of AgOTf. After another 5 min, a solution of glycosyl acceptor in anhydrous CH2Cl2 was slowly added. The resulting mixture was slowly warmed to room temperature within 2 h, stirred for another 20 min and cooled back to 78 C. The glycosylation operation
mentioned above was repeated until the generation of the desired product.
Data availability. The authors declare that the data supporting the ndingsof this study are available within the article and its Supplementary Information les. And all data are available from the authors upon reasonable request.
References
1. Varki, A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97130 (1993).
2. Bertozzi, C. R. & Kiessling, L. L. Chemical glycobiology. Science 291, 23572364 (2001).
3. Boltje, T. J., Buskas, T. & Boons, G.-J. Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research. Nat. Chem. 1, 611622 (2009).
4. Danishefsky, S. J., McClure, K. F., Randolph, J. T. & Ruggeri, R. B. A strategy for the solid-phase synthesis of oligosaccharides. Science 260, 13071309 (1993).
5. Yamada, H., Harada, T., Miyazaki, H. & Takahashi, T. One-pot sequential glycosylation: a new method for the synthesis of oligosaccharides. Tetrahedron Lett. 35, 39793982 (1994).
6. Zhang, Z. et al. Programmable one-pot oligosaccharide synthesis. J. Am. Chem. Soc. 121, 734753 (1999).
7. Plante, O. J., Palmacci, E. R. & Seeberger, P. H. Automated solid-phase synthesis of oligosaccharides. Science 291, 15231527 (2001).
8. Nigudkar, S. S. & Demchenko, A. V. Stereocontrolled 1,2-cis glycosylation as the driving force of progress in synthetic carbohydrate chemistry. Chem. Sci. 6, 26872704 (2015).
9. Wang, C.-C. et al. Regioselective one-pot protection of carbohydrates. Nature 446, 896899 (2007).
10. Matsuzaki, Y., Ito, Y., Nakahara, Y. & Ogawa, T. Synthesis of branched poly-N-acetyl-lactosamine type pentaantennary pentacosasaccharide: glycan part of a glycosyl ceramide from rabbit erythrocyte membrane. Tetrahedron Lett. 34, 10611064 (1993).
11. Pozsgay, V. A new strategy in oligosaccharide synthesis using lipophilic protecting groups: synthesis of a tetracosasaccharide. Tetrahedron: Asymmetry 11, 151172 (2000).
12. Fraser-Reid, B., Lu, J., Jayaprakash, K. N. & Lpez, J. C. Synthesis of a 28-mer oligosaccharide core of Mycobacterial lipoarabinomannan (LAM) requires only two n-pentenyl orthoester progenitors. Tetrahedron: Asymmetry 17, 24492463 (2006).
6 NATURE COMMUNICATIONS | 8:14851 | DOI: 10.1038/ncomms14851 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14851 ARTICLE
13. Cheon, H.-S., Lian, Y. & Kishi, Y. Highly stereoselective and iterative synthesis of a-(1-4)-linked polysaccharides composed of 3-O-methyl-D-mannose. Org.
Lett. 9, 33233326 (2007).14. Joe, M., Bai, Y., Nacario, R. C. & Lowary, T. L. Synthesis of the docosanasaccharide arabinan domain of mycobacterial arabinogalactanand a proposed octadecasaccharide biosynthetic precursor. J. Am. Chem. Soc. 129, 98859901 (2007).
15. Ishiwata, A. & Ito, Y. Synthesis of docosasaccharide arabinan motif of mycobacterial cell wall. J. Am. Chem. Soc. 133, 22752291 (2011).
16. Calin, O., Eller, S. & Seeberger, P. H. Automated polysaccharide synthesis: assembly of a 30mer mannoside. Angew. Chem. Int. Ed. 52, 58625865 (2013).
17. Hansen, S. U., Miller, G. J., Cliff, M. J., Jayson, G. C. & Gardiner, J. M. Making the longest sugars: a chemical synthesis of heparin-related [4]n oligosaccharides from 16-mer to 40-mer. Chem. Sci. 6, 61586164 (2015).
18. Islam, M., Shinde, G. P. & Hotha, S. Expedient synthesis of the heneicosasaccharyl mannose capped arabinomannan of the Mycobacterium tuberculosis cellular envelope by glycosyl carbonate donors. Chem. Sci. doi:10.1039/C6SC04866H (2017).
19. Brennan, P. J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 83, 9197 (2003).
20. Alderwick, L. J. et al. Deletion of Cg-emb in corynebacterianeae leads to a novel truncated cell wall arabinogalactan, whereas inactivation of Cg-ubiA results in an arabinan-decient mutant with a cell wall galactan core. J. Biol. Chem. 280, 3236232371 (2005).
21. Bhamidi, S. et al. The identication and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactan. J. Biol. Chem. 283, 1299213000 (2008).
22. Bhamidi, S. et al. Detailed structural and quantitative analysis reveals the spatial organization of the cell walls of in Vivo grown Mycobacterium leprae and in vitro grown Mycobacterium tuberculosis. J. Biol. Chem. 286, 2316823177 (2011).
23. Lowary, T. L. Twenty years of mycobacterial glycans: furanosides and beyond. Acc. Chem. Res. 49, 13791388 (2016).
24. Mereyala, H. B., Hotha, S. & Gurjar, M. K. Synthesis of pentaarabinofuranosyl structure motif A of Mycobacterium tuberculosis. J. Chem. Soc. Chem. Commun. 685686 (1998).
25. DSouza, F. W. & Lowary, T. L. The rst total synthesis of a highly branched arabinofuranosyl hexasaccharide found at the nonreducing termini of mycobacterial arabinogalactan and lipoarabinomannan. Org. Lett. 2, 14931495 (2000).
26. Completo, G. C. & Lowary, T. L. Synthesis of galactofuranose-containing acceptor substrates for mycobacterial galactofuranosyltransferases. J. Org. Chem. 73, 45134525 (2008).
27. Wang, S., Meng, X., Huang, W. & Yang, J.-S. Inuence of silyl protections on the anomeric reactivity of galactofuranosyl thioglycosides and application of the silylated thiogalactofuranosides to one-pot synthesis of diverse b-D-oligogalactofuranosides. J. Org. Chem. 79, 1020310217 (2014).
28. Kandasamy, J., Hurevich, M. & Seeberger, P. H. Automated solid phase synthesis of oligoarabinofuranosides. Chem. Commun. 49, 44534455 (2013).
29. Huang, X., Huang, L., Wang, H. & Ye, X.-S. Iterative one-pot synthesis of oligosaccharides. Angew. Chem. Int. Ed. 43, 52215224 (2004).
30. Liang, X.-Y., Deng, L.-M., Liu, X. & Yang, J.-S. Efcient one-pot syntheses of a-D-arabinofuranosyl tri- and tetrasaccharides present in cell wall polysaccharide of Mycobacterium tuberculosis. Tetrahedron 66, 8793
2010:
31. Ishiwata, A., Akao, H. & Ito, Y. Stereoselective synthesis of a fragment of mycobacterial arabinan. Org. Lett. 8, 55255528 (2006).
32. Gadikota, R. R., Callam, C. S., Wagner, T., Fraino, B. D. & Lowary, T. L. 2,3-Anhydro sugars in glycoside bond synthesis. Highly stereoselective syntheses of oligosaccharides containing a- and b-arabinofuranosyl linkages.
J. Am. Chem. Soc. 125, 41554165 (2003).33. Lee, Y. J., Lee, K., Jung, E. H., Jeon, H. B. & Kim, K. S. Acceptor-dependent stereoselective glycosylation: 20-CB glycoside-mediated direct b-D-arabinofuranosylation and efcient synthesis of the octaarabinofuranoside in mycobacterial cell wall. Org. Lett. 7, 32633266 (2005).
34. Zhu, X., Kawatkar, S., Rao, Y. & Boons, G.-J. Practical approach for the stereoselective introduction of b-arabinofuranosides. J. Am. Chem. Soc. 128, 1194811957 (2006).
35. Imamura, A. & Lowary, T. L. b-Selective arabinofuranosylation using a 2,3-O-xylylene-protected donor. Org. Lett. 12, 36863689 (2010).
36. Thadke, S. A., Mishra, B. & Hotha, S. Facile synthesis of b- and a-arabinofuranosides and application to cell wall motifs of M. tuberculosis. Org. Lett. 15, 24662469 (2013).
37. Liu, Q.-W., Bin, H.-C. & Yang, J.-S. b-Arabinofuranosylation using 5-O-(2-quinolinecarbonyl) substituted ethyl thioglycoside donors. Org. Lett. 15, 39743977 (2013).
38. Crich, D., Pedersen, C. M., Bowers, A. A. & Wink, D. J. On the use of 3,5-O-benzylidene and 3,5-O-(di-tert-butylsilylene)-2-O-benzylarabinothiofuranosides and their sulfoxides as glycosyl donors for the synthesis of b-arabinofuranosides: importance of the activation method. J. Org. Chem. 72, 15531565 (2007).
39. Mizutani, K., Kasai, R., Nakamura, M. & Tanaka, O. N.M.R. spectral study of a- and b-L-arabinofuranosides. Carbohydr. Res. 185, 2738 (1989).
40. Lee, R. E. B., Li, W., Chatterjee, D. & Lee, R. E. Rapid structure characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed. Glycobiology 15, 139151 (2005).
41. Konradsson, P., Udodong, U. E. & Fraser-Reid, B. Iodonium promoted reactions of disarmed thioglycosides. Tetrahedron Lett. 31, 43134316 (1990).
42. Vwneman, G. H., van Leeuwen, S. H. & van Boom, J. H. Iodonium ion promoted reactions at the anomeric centre. II. An efcient thioglycoside mediated approach toward the formation of 1,2-trans linked glycosides and glycosidic esters. Tetrahedron Lett. 31, 13311334 (1990).
43. Maity, S. K., Basu, N. & Ghosh, R. Efcient activation of thioglycosides with N-(p-methylphenylthio)-e-caprolactam-TMSOTf. Carbohydr. Res. 354, 4048 (2012).
44. Marra, A., Mallet, J.-M., Amatore, C. & Sina, P. Glycosylation usinga one-electron-transfer homogeneous reagent: a novel and efcient synthesis of b-linked disaccharides. Synlett 572574 (1990).
45. Goswami, M., Ellern, A. & Pohl, N. L. B. Bismuth(V)-mediated thioglycoside activation. Angew. Chem. Int. Ed. 52, 84418445 (2013).
46. Crich, D. & Smith, M. 1-Benzenesulnyl piperidine/triuoromethanesulfonic anhydride: a potent combination of shelf-stable reagents for the low-temperature conversion of thioglycosides to glycosyl triates andfor the formation of diverse glycosidic linkages. J. Am. Chem. Soc. 123, 90159020 (2001).
47. Code, J. D. C. et al. Ph2SO/Tf2O: a powerful promotor system in chemoselective glycosylations using thioglycosides. Org. Lett. 5, 15191522 (2003).
48. Wang, C., Wang, H., Huang, X., Zhang, L.-H. & Ye, X.-S. Benzenesulnyl morpholine: a new promoter for one-pot oligosaccharide synthesis using thioglycosides by pre-activation strategy. Synlett 28462850 (2006).
Acknowledgements
This work was nancially supported by the grants from the National Natural Science Foundation of China (21232002) and the Ministry of Science and Technology of China (2013CB910700, 2012CB822100). We thank Professor Qin Li and Professor Lijun Zhong at Peking University Health Science Center for their helpful assistance in analysis of glycan structures.
Author contributions
D.-C.X. and X.-S.Y. conceived the research. Y.W., D.-C.X. and X.-S.Y. designed the experiments. Y.W. performed all the experiments. S.-C.C. and Y.-S.W. synthesized some building blocks. Y.W., D.-C.X. and X.-S.Y. analyzed the data. Y.W. and X.-S.Y. wrote the manuscript. X.-S.Y. supervised the project.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications
Web End =http://www.nature.com/ http://www.nature.com/naturecommunications
Web End =naturecommunications
Competing interests: The authors declare no competing nancial interests.
Reprints and permission information is available online at http://npg.nature.com/reprintsandpermissions/
Web End =http://npg.nature.com/ http://npg.nature.com/reprintsandpermissions/
Web End =reprintsandpermissions/
How to cite this article: Wu, Y. et al. Total synthesis of mycobacterial arabinogalactan containing 92 monosaccharide units. Nat. Commun. 8, 14851 doi: 10.1038/ncomms14851 (2017).
Publishers note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional afliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the articles Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Web End =http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
NATURE COMMUNICATIONS | 8:14851 | DOI: 10.1038/ncomms14851 | http://www.nature.com/naturecommunications
Web End =www.nature.com/naturecommunications 7
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Nature Publishing Group Mar 2017
Abstract
Carbohydrates are diverse bio-macromolecules with highly complex structures that are involved in numerous biological processes. Well-defined carbohydrates obtained by chemical synthesis are essential to the understanding of their functions. However, synthesis of carbohydrates is greatly hampered by its insufficient efficiency. So far, assembly of long carbohydrate chains remains one of the most challenging tasks for synthetic chemists. Here we describe a highly efficient assembly of a 92-mer polysaccharide by the preactivation-based one-pot glycosylation protocol. Several linear and branched oligosaccharide/polysaccharide fragments ranging from 5-mer to 31-mer in length have been rapidly constructed in one-pot manner, which enables the first total synthesis of a biologically important mycobacterial arabinogalactan through a highly convergent [31+31+30] coupling reaction. Our results show that the preactivation-based one-pot glycosylation protocol may provide access to the construction of long and complicated carbohydrate chains.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer